MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,989,330 | +15.4% | 298,194 | -1.5% | 0.01% | +20.0% |
Q2 2023 | $11,258,885 | 0.0% | 302,821 | 0.0% | 0.01% | 0.0% |
Q1 2023 | $11,258,885 | +3.6% | 302,821 | +26.2% | 0.01% | -16.7% |
Q4 2022 | $10,869,960 | -99.9% | 239,902 | +18.8% | 0.01% | -25.0% |
Q3 2022 | $14,102,512,000 | -3.4% | 201,926 | -7.1% | 0.01% | 0.0% |
Q2 2022 | $14,595,337,000 | -38.3% | 217,419 | -24.4% | 0.01% | -20.0% |
Q1 2022 | $23,651,406,000 | -69.9% | 287,660 | -46.2% | 0.01% | -66.7% |
Q4 2021 | $78,488,684,000 | +9.0% | 535,065 | +31.5% | 0.03% | 0.0% |
Q3 2021 | $72,002,369,000 | +3.5% | 407,000 | -5.5% | 0.03% | 0.0% |
Q2 2021 | $69,579,209,000 | -12.5% | 430,751 | -7.2% | 0.03% | -14.3% |
Q1 2021 | $79,498,616,000 | -26.4% | 464,090 | -5.7% | 0.04% | -31.4% |
Q4 2020 | $108,066,396,000 | +0.7% | 492,016 | -23.9% | 0.05% | -12.1% |
Q3 2020 | $107,317,452,000 | +55.5% | 646,296 | +6.9% | 0.06% | +38.1% |
Q2 2020 | $69,032,890,000 | +50.1% | 604,650 | +1.0% | 0.04% | +27.3% |
Q1 2020 | $46,003,851,000 | -2.1% | 598,463 | +64.2% | 0.03% | +13.8% |
Q4 2019 | $46,973,594,000 | +155.9% | 364,532 | +54.7% | 0.03% | +141.7% |
Q3 2019 | $18,355,051,000 | +714.6% | 235,593 | +976.9% | 0.01% | +500.0% |
Q2 2019 | $2,253,331,000 | +185.7% | 21,877 | +103.3% | 0.00% | +100.0% |
Q1 2019 | $788,709,000 | +170.2% | 10,760 | +56.4% | 0.00% | – |
Q4 2018 | $291,850,000 | -31.9% | 6,880 | -24.4% | 0.00% | – |
Q3 2018 | $428,610,000 | -1.2% | 9,100 | +3.4% | 0.00% | – |
Q2 2018 | $433,840,000 | – | 8,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |